INTEGRA LIFESCIENCES HOLDINGS CORP
Price data unavailable
Track IART in your trading journalAbout INTEGRA LIFESCIENCES HOLDINGS CORP
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) is a publicly listed company on US equity markets.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
The company reports trailing twelve-month revenue of $357.08M and net loss of $4.62M.
Key metrics include a return on equity of -0.4%, a debt-to-equity ratio of 2.43.
Use FINOTAUR to track IART's price action, review fundamentals, and stay current with company news — all in one research dashboard.
Fundamentals
| Revenue (TTM) | $357.08M |
| Net Income (TTM) | $-4.62M |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | -0.44% |
| Debt-to-Equity | 2.43 |
| Dividend per Share | — |
Recent News
- Benzinga·May 22
Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It
- GlobeNewswire Inc.·May 5
Integra LifeSciences Reports First Quarter 2026 Financial Results
- GlobeNewswire Inc.·Apr 24
Tissue Engineering Market to Grow at 12.95% CAGR Reaching USD 27.59 Billion by 2031, Driven by Advances in Regenerative Medicine and Biomaterials, Says Mordor Intelligence
Want real-time analysis on IART?
Track it free in your trading journal. Log trades, tag setups, and review your edge.